BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17675252)

  • 1. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
    Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
    J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group A1 expression correlates with the histological grade of human glial tumors.
    Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
    Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?
    Kren L; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Smrcka M; Slaby O; Lakomy R; Vanhara P; Krenova Z; Michalek J
    J Neuroimmunol; 2010 Mar; 220(1-2):131-5. PubMed ID: 20167379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
    Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
    Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucose transporter and blood-brain barrier of human brain tumors.
    Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
    Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?
    Kren L; Slaby O; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Lakomy R; Vanhara P; Krenova Z; Sterba J; Smrcka M; Michalek J
    Neuropathology; 2011 Apr; 31(2):129-34. PubMed ID: 20667016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas.
    Ogden AT; Horgan D; Waziri A; Anderson D; Louca J; McKhann GM; Sisti MB; Parsa AT; Bruce JN
    Neurosurgery; 2006 Oct; 59(4):902-9; discussion 909-10. PubMed ID: 17038955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.